Certara to Report Fourth Quarter and Full Year 2020 Preliminary Financial Results on March 4, 2021
Certara, Inc. (Nasdaq: CERT) will announce its preliminary financial results for Q4 and the full year of 2020 post-market on March 4, 2021. A conference call to discuss these results will take place at 5:00 p.m. ET, accessible to investors through specific dialing options and a live webcast. Certara specializes in biosimulation technologies for drug discovery and development, serving over 1,650 biopharmaceutical companies and regulatory agencies in 61 countries.
- Serves over 1,650 global biopharmaceutical companies.
- Accelerates drug discovery through advanced biosimulation software.
- None.
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release preliminary financial results for the fourth quarter and full year of 2020 after the market close on Thursday, March 4, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (833) 360-0946 for domestic callers or (914) 987-7661 for international callers, followed by Conference ID: 6546156. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005138/en/
FAQ
What are the preliminary financial results for Certara for Q4 and 2020?
When is the conference call for Certara's financial results?
How can investors access Certara's conference call?
Where can I find the archived webcast of Certara's conference call?
